当前位置：
X-MOL 学术
›
Ther. Adva. Endocrinol. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2022-12-10 , DOI: 10.1177/20420188221139614 C Vikneshwaran Chandra Kumar 1 , Ruben Skantha 1 , Wah-Kheong Chan 2
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2022-12-10 , DOI: 10.1177/20420188221139614 C Vikneshwaran Chandra Kumar 1 , Ruben Skantha 1 , Wah-Kheong Chan 2
Affiliation
Non-alcoholic fatty liver disease (NAFLD) affects an estimated one-quarter of the global adult population and has become one of the leading causes of end-stage liver disease and hepatocellular carc...
中文翻译：
代谢功能障碍相关脂肪肝的无创评估
非酒精性脂肪性肝病 (NAFLD) 影响了全球约四分之一的成年人口，并已成为终末期肝病和肝细胞癌的主要原因之一……
更新日期：2022-12-12
中文翻译：
代谢功能障碍相关脂肪肝的无创评估
非酒精性脂肪性肝病 (NAFLD) 影响了全球约四分之一的成年人口，并已成为终末期肝病和肝细胞癌的主要原因之一……
京公网安备 11010802027423号